Malignancy-Associated Hemophagocytic Lymphohistiocytosis Secondary to Anaplastic T-Cell Lymphoma: A Case Report
This case report describes a fatal instance of malignancy-associated hemophagocytic lymphohistiocytosis (HLH) triggered by anaplastic T-cell lymphoma in a young male, illustrating how the hyperinflammatory syndrome can mask the underlying malignancy and present without classical hemophagocytosis, leading to diagnostic delays and rapid mortality.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human immune system is designed to be a vigilant defender, launching powerful attacks against invaders like bacteria and viruses. However, sometimes this defense mechanism malfunctions, turning on the body itself in a catastrophic overreaction known as hemophagocytic lymphohistiocytosis, or HLH. In this rare and dangerous condition, immune cells become hyperactive, releasing a flood of inflammatory signals that cause fever, organ failure, and the destruction of blood cells. While HLH can be triggered by severe infections or autoimmune diseases, it is also a known complication of certain cancers, particularly those involving T-cells, a type of white blood cell. When cancer drives this inflammatory storm, the outcome is often grim because the underlying tumor is difficult to spot while the body is in the throes of a crisis that mimics a severe infection. Understanding how these two conditions hide behind one another is critical for doctors, as the window to save a patient is often very narrow.
This case report details the tragic and rapid decline of a twenty-five-year-old man who arrived at a hospital in Damascus with a confusing mix of symptoms. He had suffered from worsening abdominal pain for months, but in the days leading up to his admission, he developed a high fever, yellowing of the skin and eyes, and severe vomiting. His condition deteriorated quickly, leading to confusion, breathing difficulties, and a swollen abdomen. When doctors examined him, they found his liver and spleen were massively enlarged, and his blood tests revealed a terrifying picture: his red and white blood cells and platelets were dangerously low, his liver enzymes were skyrocketing, and a protein called ferritin, which usually indicates inflammation, was elevated to an extreme level of 50,229 nanograms per milliliter. These signs pointed strongly toward HLH, a life-threatening syndrome where the body's immune system attacks its own tissues.
Despite the strong suspicion of HLH, the medical team faced a significant hurdle in finding the root cause. They rigorously tested for common culprits like bacterial infections, tuberculosis, malaria, and various viruses, but every test came back negative. The patient's blood smear showed signs of stress but no clear evidence of the specific cell destruction often seen in HLH. To investigate further, doctors performed a bone marrow aspiration, a procedure where a small sample of the liquid inside the bone is drawn out to look for abnormal cells. The first attempt showed active blood production but no signs of the immune cells eating other blood cells, a hallmark feature of the disease. A second attempt yielded nothing but a "dry tap," meaning the needle could not draw out any fluid, a sign that the marrow might be packed solid with something else. Even without seeing the classic cellular evidence, the doctors calculated a clinical score based on the patient's fever, organ size, and blood levels, which indicated a greater than ninety-three percent probability that the patient was suffering from HLH.
The patient's condition continued to worsen despite intensive care. He was placed on a ventilator to help him breathe and given high doses of steroids to calm his immune system, but his body did not respond. He suffered seizures and shock, passing away on the fifth day of his hospital stay. It was only after his death, when a pathologist examined a solid sample of his bone marrow tissue, that the true cause was revealed. The tissue was filled with abnormal, large cancer cells that tested positive for a specific marker called CD30. This confirmed that the man had anaplastic large-cell lymphoma, a type of T-cell cancer. The cancer had triggered the massive inflammatory storm, but the cancer cells were so deeply embedded in the marrow that the initial liquid tests had missed them entirely.
This case serves as a stark reminder of how malignancy-associated HLH can dominate a patient's clinical picture, completely obscuring the underlying cancer until it is too late. The report highlights that the absence of the classic "eating" cells in a bone marrow sample does not rule out the disease, especially when the marrow is infiltrated by cancer. The doctors found that the cancer cells were producing a storm of inflammatory signals that drove the immune system into a frenzy, leading to rapid organ failure. The study concludes that when a patient presents with signs of a severe infection that does not respond to antibiotics, combined with low blood counts and massive organ swelling, doctors must consider the possibility of an underlying T-cell lymphoma. A non-diagnostic bone marrow test or a dry tap should not end the investigation but should instead prompt a deeper look for hidden cancer, as delays in recognizing this specific combination of conditions can lead to fatal outcomes.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.